Your Best Stock
Stocks › NVO

Novo-Nordisk A/S NVO

US equityMarket cap rank #90
$38.33
+$0.16 (+0.41%)
Market open · Sep 24, 2:00 pm ET
After hours $38.21 +0.11%
Open$37.97
Prev close$38.17
Day range$37.92 – $38.72
Volume13.27M
Market cap$171.13B
P/E (TTM)9.6
Dividend yield4.65%

Earnings

Average move on report day±4.6%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+17.1%
Worst reaction-11.3%

Stock move on the day after each report

+3.3%2023/Q3+5.2%2023/Q4-4.0%2024/Q1-8.4%2024/Q2-4.3%2024/Q3+3.8%2024/Q4+1.9%2025/Q1-3.9%2025/Q2+0.4%2025/Q3-6.2%2025/Q4+2.0%2026/Q1+0.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026–±1.5%+0.56%Within range
2026/Q16 May 2026–±3.0%+1.98%Within range
2025/Q44 Feb 2026–±3.0%-6.18%Bigger than priced
2025/Q35 Nov 2025–±4.1%+0.44%Within range
2025/Q26 Aug 2025Pre Market±2.9%-3.90%Bigger than priced
2025/Q17 May 2025Pre Market±4.7%+1.90%Within range
2024/Q45 Feb 2025–±5.9%+3.76%Within range
2024/Q36 Nov 2024–±7.5%-4.33%Within range
2024/Q27 Aug 2024–±9.3%-8.37%Within range
2024/Q12 May 2024–±7.0%-4.02%Within range
2023/Q431 Jan 2024Pre Market±6.3%+5.25%Within range
2023/Q32 Nov 2023Pre Market±4.6%+3.33%Within range
2022/Q41 Feb 2023–±9.2%+0.22%Within range
2016/Q25 Aug 2016––-11.26%–
2011/Q327 Oct 2011––+17.10%–
2011/Q128 Apr 2011––+1.28%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Obesity and Diabetes careDKK 73.58B 93.7%
  • Rare DiseaseDKK 4.91B 6.3%

Latest reported quarter: Q2, ended Jun 2026 · reported in DKK

RevenueDKK 78.49B+2.1% YoY
Operating profitDKK 27.06B-19.1% YoY
Net profitDKK 20.99B-20.8% YoY
Diluted EPSDKK 4.74-20.5% YoY
Free cash flowDKK 12.05B+18.7% YoY
Operating cash flowDKK 24.08B

Revenue, last 8 quarters

DKK 71.3BSep '24DKK 85.7BDec '24DKK 78.1BMar '25DKK 76.9BJun '25DKK 75.0BSep '25DKK 79.1BDec '25DKK 96.8BMar '26DKK 78.5BJun '26

Net profit, last 8 quarters

DKK 27.3BSep '24DKK 28.2BDec '24DKK 29.0BMar '25DKK 26.5BJun '25DKK 20.0BSep '25DKK 26.9BDec '25DKK 48.6BMar '26DKK 21.0BJun '26

Profitability & balance sheet

Gross margin80.6%
Operating margin43.1%
Net margin35.3%
Return on equity59.8%
Return on assets21.6%
Return on invested capital36.8%
Current ratio0.87
Liabilities / assets62.8%
Cash & investmentsDKK 44.98B
Total debtDKK 140.13B
Net cash (debt)-DKK 95.15B
Free cash flow / sales14.5%
Scroll to Top